DKK2 and Alzheimer disease: To analyze microglial DKK2 expression in humans, we obtained human postmortem frontal cortex brain tissue from healthy control individuals, as well as individuals diagnosed with AD and pathologic aging, the latter being defined as nondemented individuals with AD-typical histopathologic changes.